Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

InSite Vision and Bausch & Lomb announce alliance regarding glaucoma drug

July 26, 1996

New formulation of CGP-41251

July 26, 1996

IL-2/interferon alpha/5-FU combination effective against metastatic renal cancer

July 26, 1996

Biogal describes cyclosporin emulsions

July 26, 1996

Erythropoietin claimed as chronic inflammation treatment

July 26, 1996

Chlorhexidine gluconate effective in reducing incidence of nosocomial respiratory tract infections

July 26, 1996

Xoma claims rBPI21 + antibiotic combination for Gram-negative infections

July 26, 1996

Pimilprost shows wound healing properties in preclinical studies

July 26, 1996

Ulinastatin claimed by Mochida as skin disorder treatment

July 26, 1996

SEPA-ibuprofen formulation fares well in phase II trial

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.